Clinical Trial

Exercise Intervention and Immunodeficiency

Name: Exercise Intervention and Immunodeficiency — clinical trial record (NCT07698197)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting

View on ClinicalTrials.gov →

Summary

The purpose of this study is to assess if a 12-week exercise program is safe, practical, and acceptable for adults with primary antibody deficiencies. It also looks at whether the program can improve the quality of life and help the immune system work better.

Protocol Amendment History 1 change

critical Recruitment opened 2026-07-24

Trial Details

NCT Number	NCT07698197
Lead Sponsor	Yale University Collaborators: The Pump
Conditions	Primary Antibody Deficiency Disorders
Enrollment	20 participants
Start Date	2026-07-17
Primary Completion	2027-07 (estimated)
Study Completion	2027-07 (estimated)
Updated on ClinicalTrials.gov	2026-07-23